Jeff Spraggins
-
Spraggins awarded $4M NSF grant to develop next-generation molecular imaging platform
In addition to fueling cutting-edge research, a new molecular imaging system will serve as a cornerstone resource at the Mass Spectrometry Research Center, which is recognized nationally as a hub for molecular imaging and technology development. It will be made accessible to collaborators across academia, national labs, and industry, ensuring broad impact. Read MoreSep. 30, 2025
-
Kidney atlas maps molecular landscape, unlocking clues to renal health and disease
In a landmark study published in Science Advances, Vanderbilt researchers have created the first high-resolution lipid atlas of the human kidney, mapping over 100,000 functional tissue units across 29 donors. By integrating advanced imaging mass spectrometry with microscopy using machine learning, the team identified distinct lipid signatures that could transform diagnostics and precision treatments for kidney disease. Read MoreJun. 17, 2025
-
Kidney atlas maps molecular landscape, unlocking clues to renal health and disease
In a landmark study published in Science Advances, Vanderbilt researchers have created the first high-resolution lipid atlas of the human kidney, mapping over 100,000 functional tissue units across 29 donors. By integrating advanced imaging mass spectrometry with microscopy using machine learning, the team identified distinct lipid signatures that could transform diagnostics and precision treatments for kidney disease. Read MoreJun. 17, 2025
-
Vanderbilt building molecular atlas of colorectal cancer across different stages of disease onset with $5 million National Cancer Institute grant
Colorectal cancer is the second leading cause of cancer-related deaths in the U.S. Ken Lau and Jeffrey Spraggins are creating the first spatially mapped atlas characterizing the progression trajectories of early-onset colorectal cancer versus average-onset CRC as they transition from precancerous lesions to malignant cancers. Read MoreNov. 20, 2024